SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-009280
Filing Date
2024-03-27
Accepted
2024-03-27 20:47:19
Documents
1
Period of Report
2024-03-27

Document Format Files

Seq Description Document Type Size
1 form4-03282024_120312.html 4  
1 form4-03282024_120312.xml 4 3165
  Complete submission text file 0001415889-24-009280.txt   4558
Mailing Address 132 PURDURE AVENUE KENGSINGTON CA 94708
Business Address
BJERKHOLT ERIC (Reporting) CIK: 0001197350 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38981 | Film No.: 24793062

Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Issuer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)